,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,3,22.1,Malignant neoplasm progression,16915226
1,5,22.1,Death,16915226
2,3,22.1,Asthenia,16915226
3,3,22.1,Influenza,16915226
4,3,22.1,Bone pain,16915226
5,3,22.1,Decreased appetite,16915226
6,3,22.1,Cardiac disorder,16915226
7,3,22.1,Movement disorder,16915226
0,2,22.1,Pneumonitis,16915250
1,5,22.1,Malignant neoplasm progression,16915250
0,6,22.1,Malignant neoplasm progression,16915263
0,6,22.1,Malignant neoplasm progression,16915264
0,6,22.1,Malignant neoplasm progression,16915266
1,6,22.1,Drug resistance,16915266
0,6,22.1,Gilbert^s syndrome,16915284
0,3,22.1,Alopecia,16915316
1,3,22.1,Hair texture abnormal,16915316
2,3,22.1,Hair colour changes,16915316
3,3,22.1,Madarosis,16915316
4,3,22.1,Hair disorder,16915316
0,3,22.1,Neuropathy peripheral,16915323
0,5,22.1,Pneumonitis,16915327
0,6,22.1,Malignant neoplasm progression,16915329
0,6,22.1,Malignant neoplasm progression,16915330
0,6,22.1,Renal scan abnormal,16915338
1,6,22.1,Liver scan abnormal,16915338
2,6,22.1,Pleural effusion,16915338
3,6,22.1,Ovarian cancer recurrent,16915338
4,6,22.1,Drug ineffective,16915338
5,6,22.1,Mesenteric artery thrombosis,16915338
0,4,22.1,Peripheral sensory neuropathy,16915435
1,4,22.1,Skin exfoliation,16915435
0,6,22.1,Breast cancer,16915436
1,6,22.1,Metastases to lymph nodes,16915436
2,6,22.1,Neoplasm recurrence,16915436
3,6,22.1,Cardiomyopathy,16915436
4,6,22.1,Invasive ductal breast carcinoma,16915436
5,6,22.1,Metastases to liver,16915436
6,6,22.1,Metastases to lung,16915436
7,6,22.1,Pulmonary mass,16915436
8,6,22.1,Lymphadenopathy,16915436
9,6,22.1,Malignant neoplasm progression,16915436
0,5,22.1,Pseudomonal bacteraemia,16915440
1,5,22.1,Hypotension,16915440
2,5,22.1,Poisoning,16915440
3,5,22.1,Agranulocytosis,16915440
4,5,22.1,Sepsis,16915440
5,5,22.1,Neutropenia,16915440
6,5,22.1,Septic shock,16915440
0,1,22.1,Acute kidney injury,16915458
1,1,22.1,Radiation skin injury,16915458
2,1,22.1,Mucosal inflammation,16915458
0,6,22.1,Myalgia,16915552
1,6,22.1,Red blood cell count decreased,16915552
2,6,22.1,Muscular weakness,16915552
3,6,22.1,Fatigue,16915552
4,6,22.1,Neutrophil count abnormal,16915552
5,6,22.1,Carpal tunnel syndrome,16915552
6,6,22.1,Platelet count decreased,16915552
0,5,22.1,Cholestasis,16915608
0,1,22.1,Febrile neutropenia,16915637
1,1,22.1,Pneumonia,16915637
0,2,22.1,Asthenia,16915643
1,2,22.1,Headache,16915643
2,2,22.1,Malignant neoplasm progression,16915643
3,2,22.1,Protein total increased,16915643
4,2,22.1,Immunosuppression,16915643
5,2,22.1,Platelet count decreased,16915643
6,2,22.1,White blood cell count increased,16915643
0,4,22.1,Abdominal discomfort,16915644
1,4,22.1,Febrile neutropenia,16915644
2,4,22.1,Colitis,16915644
0,1,22.1,Dyspnoea,16915645
1,1,22.1,Pruritus,16915645
2,1,22.1,Heart rate increased,16915645
3,1,22.1,Feeling hot,16915645
4,1,22.1,Nausea,16915645
5,1,22.1,Blood pressure increased,16915645
6,1,22.1,Flushing,16915645
7,1,22.1,Restless legs syndrome,16915645
0,6,22.1,Ascites,16915646
1,6,22.1,Rash,16915646
2,6,22.1,Skin exfoliation,16915646
0,6,22.1,Pruritus,16915655
1,6,22.1,Nausea,16915655
2,6,22.1,Vomiting,16915655
3,6,22.1,Infusion related reaction,16915655
4,6,22.1,Erythema,16915655
0,1,22.1,Pruritus,16915669
1,1,22.1,Vomiting,16915669
2,1,22.1,Infusion related reaction,16915669
3,1,22.1,Nausea,16915669
4,1,22.1,Erythema,16915669
0,1,22.1,Hyperhidrosis,16915724
1,1,22.1,Unresponsive to stimuli,16915724
2,1,22.1,Heart rate increased,16915724
3,1,22.1,Feeling hot,16915724
4,1,22.1,Oxygen saturation decreased,16915724
5,1,22.1,Flushing,16915724
6,1,22.1,Blood pressure decreased,16915724
7,1,22.1,Nausea,16915724
0,1,22.1,Diarrhoea,16915726
1,1,22.1,Febrile neutropenia,16915726
2,1,22.1,Gastrointestinal disorder,16915726
3,1,22.1,Pyrexia,16915726
4,1,22.1,Fatigue,16915726
5,1,22.1,Dehydration,16915726
6,1,22.1,Nausea,16915726
7,1,22.1,Vomiting,16915726
0,2,22.1,Heart rate irregular,16915728
1,2,22.1,Metastases to liver,16915728
2,2,22.1,Chest pain,16915728
3,2,22.1,Skin exfoliation,16915728
4,2,22.1,Drug hypersensitivity,16915728
5,2,22.1,Neuropathy peripheral,16915728
6,2,22.1,Diarrhoea,16915728
7,2,22.1,Rash,16915728
8,2,22.1,Asthma,16915728
9,2,22.1,Breast cancer metastatic,16915728
10,2,22.1,Device related thrombosis,16915728
11,2,22.1,Metastases to bone,16915728
12,2,22.1,Nail disorder,16915728
13,2,22.1,Nausea,16915728
14,2,22.1,Paraesthesia,16915728
15,2,22.1,Vomiting,16915728
16,2,22.1,Drug ineffective,16915728
0,3,22.1,Amnesia,16915789
1,3,22.1,Ammonia increased,16915789
0,2,22.1,Hypocalcaemia,16915806
1,2,22.1,Asthenia,16915806
2,2,22.1,Malaise,16915806
3,2,22.1,Transaminases increased,16915806
4,2,22.1,Diarrhoea,16915806
0,3,22.1,Osteoporosis,16915812
1,3,22.1,Breast cancer metastatic,16915812
2,3,22.1,Concomitant disease aggravated,16915812
3,3,22.1,Cough,16915812
4,3,22.1,Invasive lobular breast carcinoma,16915812
5,3,22.1,Malignant neoplasm progression,16915812
6,3,22.1,Dysphonia,16915812
7,3,22.1,Lymphadenopathy,16915812
8,3,22.1,Weight decreased,16915812
9,3,22.1,Diarrhoea,16915812
10,3,22.1,Metastases to lymph nodes,16915812
0,6,22.1,Pollakiuria,16915845
1,6,22.1,Tremor,16915845
2,1,22.1,Pyrexia,16915845
3,6,22.1,Headache,16915845
4,6,22.1,Chills,16915845
5,6,22.1,Granulomatous liver disease,16915845
0,1,22.1,Dyspnoea,16915852
1,1,22.1,Back pain,16915852
2,6,22.1,Herpes zoster,16915852
3,1,22.1,Anaphylactoid reaction,16915852
4,1,22.1,Injection site pruritus,16915852
5,1,22.1,Injection site erythema,16915852
6,1,22.1,Hypersensitivity,16915852
7,6,22.1,Rash,16915852
0,1,22.1,Colitis,16915859
0,1,22.1,Febrile neutropenia,16915907
1,1,22.1,Product use in unapproved indication,16915907
0,1,22.1,Vomiting,16915936
0,6,22.1,Carbohydrate antigen 125 increased,16915944
1,6,22.1,Constipation,16915944
2,6,22.1,Infusion related reaction,16915944
3,6,22.1,Rectal haemorrhage,16915944
0,2,22.1,Wernicke^s encephalopathy,16915945
0,6,22.1,C-reactive protein increased,16915958
1,6,22.1,Lung opacity,16915958
2,2,22.1,Interstitial lung disease,16915958
3,6,22.1,Malignant neoplasm progression,16915958
4,2,22.1,Pneumonia,16915958
5,6,22.1,Imaging procedure abnormal,16915958
6,1,22.1,Bone marrow failure,16915958
0,5,22.1,Adrenal mass,16915978
1,5,22.1,Hilar lymphadenopathy,16915978
2,5,22.1,Lung neoplasm,16915978
3,5,22.1,Acute respiratory failure,16915978
4,5,22.1,Splenomegaly,16915978
5,5,22.1,Dyspnoea,16915978
6,5,22.1,Neoplasm progression,16915978
7,5,22.1,Breast calcifications,16915978
8,5,22.1,Hepatic cancer,16915978
9,5,22.1,Hepatic steatosis,16915978
10,5,22.1,Pulmonary mass,16915978
11,5,22.1,Breast mass,16915978
12,5,22.1,Febrile neutropenia,16915978
13,5,22.1,Hepatic lesion,16915978
14,5,22.1,Nausea,16915978
15,5,22.1,Renal failure,16915978
16,5,22.1,Vomiting,16915978
17,5,22.1,Second primary malignancy,16915978
18,5,22.1,Lymphadenopathy mediastinal,16915978
19,5,22.1,Pyrexia,16915978
20,5,22.1,Stomatitis,16915978
0,1,22.1,Flushing,16916033
1,1,22.1,Nausea,16916033
2,1,22.1,Dyspnoea,16916033
3,1,22.1,Chills,16916033
4,1,22.1,Diarrhoea,16916033
5,1,22.1,Tachypnoea,16916033
6,1,22.1,Vomiting,16916033
0,3,22.1,Groin pain,16916050
1,3,22.1,Arthralgia,16916050
2,1,22.1,Pain in extremity,16916050
0,6,22.1,Fatigue,16916076
1,6,22.1,Neutropenia,16916076
2,6,22.1,Malignant neoplasm progression,16916076
3,6,22.1,Pain,16916076
4,6,22.1,Asthenia,16916076
5,6,22.1,Tumour marker increased,16916076
0,1,22.1,Chest discomfort,16916088
1,1,22.1,Dizziness,16916088
2,1,22.1,Dehydration,16916088
3,1,22.1,Flushing,16916088
4,1,22.1,Visual impairment,16916088
0,,22.1,Syringe issue,16916200
1,,22.1,Product preparation error,16916200
0,6,22.1,Cough,16916206
1,6,22.1,Hypotension,16916206
2,6,22.1,Dyspnoea,16916206
3,6,22.1,Hypoxia,16916206
4,6,22.1,Chest discomfort,16916206
5,6,22.1,Flushing,16916206
0,6,22.1,Neoplasm recurrence,16916252
0,1,22.1,Erysipelas,16916259
0,3,22.1,Insomnia,16916271
1,3,22.1,Injection site pain,16916271
2,3,22.1,Weight decreased,16916271
3,3,22.1,Breast cancer,16916271
4,3,22.1,Nausea,16916271
5,3,22.1,Chest discomfort,16916271
6,3,22.1,Depression,16916271
7,3,22.1,Dyspnoea exertional,16916271
8,3,22.1,Paraesthesia oral,16916271
9,3,22.1,Anxiety,16916271
10,3,22.1,Decreased appetite,16916271
11,3,22.1,Dyspnoea at rest,16916271
12,3,22.1,Fatigue,16916271
13,3,22.1,Urticaria,16916271
0,5,22.1,Respiratory failure,16916300
1,5,22.1,Myasthenic syndrome,16916300
0,6,22.1,Product communication issue,16916307
0,,22.1,Product leakage,16916311
1,,22.1,Intercepted product preparation error,16916311
0,6,22.1,Neoplasm recurrence,16916313
0,6,22.1,Neurotoxicity,16916314
1,6,22.1,Malignant neoplasm progression,16916314
2,2,22.1,Paraesthesia,16916314
0,5,22.1,Prostate cancer,16916327
0,1,22.1,Chest pain,16916339
1,1,22.1,Nausea,16916339
2,1,22.1,Dermatitis exfoliative generalised,16916339
3,1,22.1,Hypotension,16916339
0,3,22.1,Systemic lupus erythematosus,16916341
0,6,22.1,Intra-abdominal fluid collection,16916359
1,6,22.1,Drug ineffective,16916359
0,3,22.1,Sepsis,16916361
0,6,22.1,Arthropathy,16916365
0,2,22.1,Viral infection,16916423
0,3,22.1,Visual impairment,16916425
1,2,22.1,Urinary retention,16916425
2,1,22.1,Hot flush,16916425
3,6,22.1,Pain in extremity,16916425
4,1,22.1,Depression,16916425
5,6,22.1,Limb discomfort,16916425
0,6,22.1,Product use in unapproved indication,16916445
1,2,22.1,Infection,16916445
0,5,22.1,Interstitial lung disease,16916463
1,5,22.1,Dyspnoea,16916463
0,6,22.1,Diarrhoea,16916465
1,1,22.1,Pneumonia,16916465
2,6,22.1,Treatment failure,16916465
3,6,22.1,Stomatitis,16916465
4,6,22.1,Transfusion,16916465
0,6,22.1,General physical health deterioration,16916512
1,6,22.1,Taste disorder,16916512
2,6,22.1,Liver disorder,16916512
0,3,22.1,Anaemia,16916558
0,1,22.1,Vomiting,16916573
1,1,22.1,Dizziness,16916573
2,1,22.1,Headache,16916573
3,1,22.1,Nausea,16916573
0,6,22.1,Lip swelling,16916641
1,6,22.1,Device use error,16916641
2,6,22.1,Pruritus,16916641
0,5,22.1,Pulmonary fibrosis,16916655
1,5,22.1,Respiratory failure,16916655
2,5,22.1,Pneumonitis,16916655
3,5,22.1,Pulmonary toxicity,16916655
0,,22.1,Rash,16918523
0,,22.1,Disease progression,16918615
0,,22.1,Diarrhoea,16918659
1,,22.1,Erythema,16918659
2,,22.1,Nausea,16918659
0,,22.1,Fatigue,16918711
1,,22.1,Dyspnoea,16918711
0,,22.1,Haematotoxicity,16918714
0,,22.1,Cardiac operation,16918730
1,,22.1,Incision site impaired healing,16918730
0,,22.1,Nausea,16918842
1,,22.1,Vomiting,16918842
0,,22.1,Accidental overdose,16918846
1,,22.1,Loss of consciousness,16918846
0,,22.1,Death,16919179
0,,22.1,Gout,16919193
1,,22.1,Fluid retention,16919193
0,,22.1,Therapy change,16919214
1,,22.1,Hepatic cancer,16919214
0,,22.1,Fatigue,16919229
0,,22.1,Hypophagia,16919298
1,,22.1,Malignant neoplasm progression,16919298
2,,22.1,Weight decreased,16919298
0,,22.1,Cerebrovascular accident,16919390
0,,22.1,Death,16919487
0,,22.1,Gait disturbance,16919514
1,,22.1,Neuropathy peripheral,16919514
0,,22.1,Adverse drug reaction,16986494
1,,22.1,Infusion related reaction,16986494
2,,22.1,Back pain,16986494
0,,22.1,Back pain,16986496
1,,22.1,Adverse drug reaction,16986496
2,,22.1,Infusion related reaction,16986496
0,,22.1,Dyspepsia,17010755
0,,22.1,Hepatitis B,17011672
0,,22.1,Rash,17011678
0,,22.1,Pancytopenia,17011685
0,,22.1,Nausea,17011736
0,,22.1,Paraesthesia,17011828
1,,22.1,Mouth swelling,17011828
2,,22.1,Oral pain,17011828
0,,22.1,Prostatic specific antigen increased,17012742
0,,22.1,Rash,17012757
0,,22.1,Dysphagia,17012762
0,,22.1,Pain,17012914
1,,22.1,Arthralgia,17012914
0,,22.1,Death,17012918
0,,22.1,Glossodynia,17012995
1,,22.1,Tongue discolouration,17012995
0,,22.1,Diarrhoea,17013029
1,,22.1,Hot flush,17013029
0,,22.1,Diarrhoea,17013080
0,,22.1,Fall,17013137
1,,22.1,Thrombosis,17013137
0,,22.1,Cellulitis,17013139
0,,22.1,Cerebrovascular accident,17013170
0,,22.1,Neuropathy peripheral,17013173
1,,22.1,Condition aggravated,17013173
0,,22.1,Peripheral swelling,17013174
1,,22.1,Headache,17013174
2,,22.1,Alopecia,17013174
0,,22.1,Peripheral swelling,17013316
1,,22.1,Joint swelling,17013316
0,,22.1,Death,17013351
0,,22.1,Muscle spasms,17013353
0,,22.1,Cerebrovascular accident,17013362
0,,22.1,Death,17013424
0,,22.1,Rash,17014818
0,,22.1,Fatigue,17015260
1,,22.1,Feeling abnormal,17015260
0,,22.1,White blood cell count decreased,17015751
1,,22.1,Therapy cessation,17015751
0,,22.1,Disease progression,17015963
1,,22.1,Blood pressure decreased,17015963
2,,22.1,Weight decreased,17015963
0,,22.1,Hypertension,17016087
0,,22.1,Abdominal discomfort,17016136
1,,22.1,Rash,17016136
0,,22.1,Pyrexia,17016147
1,,22.1,Haematochezia,17016147
2,,22.1,Influenza like illness,17016147
3,,22.1,Decreased appetite,17016147
4,,22.1,Renal impairment,17016147
5,,22.1,Carbohydrate antigen 125 increased,17016147
6,,22.1,Tumour compression,17016147
7,,22.1,Drug ineffective,17016147
8,,22.1,Neoplasm progression,17016147
9,,22.1,Fatigue,17016147
10,,22.1,Constipation,17016147
11,,22.1,Chills,17016147
12,,22.1,Urine analysis abnormal,17016147
0,,22.1,Hyperglycaemia,17016298
1,,22.1,Rash,17016298
2,,22.1,Dry mouth,17016298
0,,22.1,Weight decreased,17016369
1,,22.1,Gastrooesophageal reflux disease,17016369
0,,22.1,Full blood count decreased,17016439
0,,22.1,Disease progression,17016753
0,,22.1,Nail disorder,17016756
0,,22.1,Malaise,17016872
0,,22.1,Palmar-plantar erythrodysaesthesia syndrome,17017086
1,,22.1,Headache,17017086
2,,22.1,Joint swelling,17017086
0,,22.1,Nausea,17017088
1,,22.1,Tooth disorder,17017088
2,,22.1,Vomiting,17017088
3,,22.1,Diarrhoea,17017088
0,,22.1,Pneumonitis,17017441
0,,22.1,White blood cell count decreased,17018135
0,,22.1,Constipation,17018193
0,,22.1,Diarrhoea,17019877
1,,22.1,Oral pain,17019877
2,,22.1,Nail discolouration,17019877
3,,22.1,Visual impairment,17019877
4,,22.1,Asthenia,17019877
0,,22.1,Amnesia,17019882
0,,22.1,Bone pain,17019946
0,,22.1,Drug ineffective,17020529
1,,22.1,Renal failure,17020529
0,,22.1,Swelling,17020711
1,,22.1,Rash,17020711
2,,22.1,Swelling face,17020711
3,,22.1,Pyrexia,17020711
0,,22.1,Diarrhoea,17020713
1,,22.1,Vomiting,17020713
2,,22.1,Rash,17020713
0,,22.1,Pruritus,17020899
1,,22.1,Herpes zoster,17020899
2,,22.1,Pain,17020899
3,,22.1,Rash,17020899
0,,22.1,Hypertension,17020967
1,,22.1,Headache,17020967
2,,22.1,Ventricular dysfunction,17020967
0,,22.1,Dyspnoea,17020987
0,,22.1,Neutropenia,17021173
0,,22.1,Hip arthroplasty,17021231
0,,22.1,Thrombectomy,17021280
0,,22.1,Hospitalisation,17021310
1,,22.1,Adverse event,17021310
2,,22.1,Product use issue,17021310
0,,22.1,Death,17021515
0,,22.1,Blood testosterone decreased,17021551
1,,22.1,Night sweats,17021551
2,,22.1,Insomnia,17021551
3,,22.1,Urinary tract infection,17021551
4,,22.1,Loss of libido,17021551
5,,22.1,Hot flush,17021551
6,,22.1,Myocardial infarction,17021551
0,,22.1,Nausea,17021704
1,,22.1,Abdominal pain upper,17021704
2,,22.1,Dyspepsia,17021704
0,,22.1,Pain,17021799
0,,22.1,Pneumonia,17022017
0,,22.1,Prostatic specific antigen increased,17022118
1,,22.1,Drug ineffective,17022118
0,,22.1,Hospitalisation,17022149
0,,22.1,Diarrhoea,17022360
0,,22.1,Diarrhoea,17022401
0,,22.1,Pharyngeal swelling,17022409
1,,22.1,Mouth swelling,17022409
2,,22.1,Hypersensitivity,17022409
3,,22.1,Swollen tongue,17022409
0,,22.1,Diarrhoea,17022452
1,,22.1,Cerebrovascular accident,17022452
0,,22.1,Lip swelling,17022876
1,,22.1,Rash macular,17022876
2,,22.1,Diarrhoea,17022876
0,,22.1,Therapy cessation,17022999
1,,22.1,Seizure,17022999
0,,22.1,Therapy cessation,17023142
1,,22.1,Nausea,17023142
0,,22.1,Muscle atrophy,17023180
0,,22.1,Death,17023362
0,,22.1,Decreased appetite,17025171
1,,22.1,Weight decreased,17025171
0,,22.1,Diarrhoea,17025228
1,,22.1,Fatigue,17025228
2,,22.1,Metastases to bone,17025228
3,,22.1,Red blood cell count decreased,17025228
4,,22.1,White blood cell count decreased,17025228
5,,22.1,Dry skin,17025228
0,,22.1,Therapy cessation,17025524
1,,22.1,Platelet count decreased,17025524
2,,22.1,Blood count abnormal,17025524
0,,22.1,Alopecia,17025586
1,,22.1,Therapy cessation,17025586
0,,22.1,Flank pain,17025641
1,,22.1,Gait inability,17025641
0,,22.1,Ocular neoplasm,17025650
1,,22.1,Sensory disturbance,17025650
2,,22.1,Tumour excision,17025650
3,,22.1,Fall,17025650
0,,22.1,Cerebrovascular accident,17025682
1,,22.1,Diarrhoea,17025682
0,,22.1,Thrombosis,17025699
0,,22.1,Fall,17025968
1,,22.1,Cataract operation,17025968
2,,22.1,Rib fracture,17025968
0,,22.1,Fatigue,17026003
0,,22.1,Arthralgia,17026521
1,,22.1,Hot flush,17026521
0,,22.1,Therapy cessation,17026612
1,,22.1,Blister,17026612
0,,22.1,Blood glucose increased,17026622
1,,22.1,Incorrect dose administered,17026622
0,,22.1,Vomiting,17026648
1,,22.1,Diarrhoea,17026648
0,,22.1,Drug ineffective,17026660
0,,22.1,Drug hypersensitivity,17026872
0,,22.1,Muscle spasms,17026985
1,,22.1,Epistaxis,17026985
2,,22.1,Myalgia,17026985
0,,22.1,Pain,17027014
0,,22.1,Drug hypersensitivity,17027025
0,,22.1,Gallbladder operation,17027159
1,,22.1,Staphylococcal infection,17027159
0,,22.1,Fatigue,17027169
1,,22.1,Dry mouth,17027169
2,,22.1,Weight decreased,17027169
3,,22.1,Back pain,17027169
4,,22.1,Decreased appetite,17027169
5,,22.1,Dehydration,17027169
0,,22.1,Off label use,17027214
0,,22.1,Hyperhidrosis,17027266
1,,22.1,Hot flush,17027266
2,,22.1,Anxiety,17027266
3,,22.1,Mood altered,17027266
4,,22.1,Depressed mood,17027266
5,,22.1,Fatigue,17027266
6,,22.1,Anger,17027266
0,,22.1,Diarrhoea,17027360
0,,22.1,Disability,17027386
1,,22.1,Arthralgia,17027386
0,,22.1,Dyspnoea,17027471
1,,22.1,Chest discomfort,17027471
0,,22.1,Disease progression,17027507
0,,22.1,Vomiting,17027572
0,,22.1,Swelling face,17027591
1,,22.1,Joint swelling,17027591
0,,22.1,Weight decreased,17027596
1,,22.1,Diarrhoea,17027596
2,,22.1,Gastric disorder,17027596
0,,22.1,Burning sensation,17027599
0,,22.1,Heart rate increased,17027627
1,,22.1,Chest discomfort,17027627
0,,22.1,Nausea,17027649
1,,22.1,Diarrhoea,17027649
0,,22.1,Vomiting,17027677
1,,22.1,Dehydration,17027677
2,,22.1,Diarrhoea,17027677
0,,22.1,Hypoaesthesia oral,17027681
1,,22.1,Hypoaesthesia,17027681
2,,22.1,Stomatitis,17027681
3,,22.1,Fatigue,17027681
0,,22.1,Cough,17027713
0,,22.1,Dyspnoea,17027718
1,,22.1,Dyspnoea exertional,17027718
0,,22.1,Drug ineffective,17027808
0,,22.1,Sepsis,17027820
1,,22.1,Vomiting,17027820
2,,22.1,Diarrhoea,17027820
0,,22.1,Arthralgia,17027845
0,,22.1,Transient ischaemic attack,17027898
0,,22.1,Dizziness,17028358
0,,22.1,Metastatic neoplasm,17028368
1,,22.1,Ileus,17028368
2,,22.1,Small intestinal obstruction,17028368
0,,22.1,Hypoaesthesia,17030409
0,,22.1,White blood cell count decreased,17030472
1,,22.1,Renal impairment,17030472
0,,22.1,Jaundice,17030478
1,,22.1,Pleural effusion,17030478
0,,22.1,Product dose omission,17030515
1,,22.1,Hospitalisation,17030515
0,,22.1,Arthralgia,17030872
1,,22.1,Neutrophil count decreased,17030872
2,,22.1,Bone pain,17030872
0,,22.1,Fatigue,17030886
1,,22.1,Loss of personal independence in daily activities,17030886
0,,22.1,Drug ineffective,17031534
1,,22.1,Haematochezia,17031534
2,,22.1,Abdominal pain upper,17031534
3,,22.1,Abdominal distension,17031534
4,,22.1,Unevaluable event,17031534
0,,22.1,White blood cell count decreased,17031728
0,,22.1,Colitis,17031758
0,,22.1,Hospitalisation,17031796
1,,22.1,Therapy cessation,17031796
0,,22.1,Dyspnoea,17031801
1,,22.1,Pain,17031801
0,,22.1,Skin fissures,17031945
1,,22.1,Dry skin,17031945
0,,22.1,White blood cell count decreased,17032080
1,,22.1,Urinary tract infection,17032080
0,,22.1,Diarrhoea,17032152
0,,22.1,Bone cancer,17032257
0,,22.1,Yellow skin,17032276
1,,22.1,Periorbital swelling,17032276
2,,22.1,Ocular hyperaemia,17032276
3,,22.1,Ocular icterus,17032276
4,,22.1,Hepatic enzyme increased,17032276
0,,22.1,Hypersensitivity,17032479
0,,22.1,Blood pressure increased,17032532
1,,22.1,Cardiac disorder,17032532
2,,22.1,Therapy change,17032532
3,,22.1,Headache,17032532
0,,22.1,Surgery,17032557
0,,22.1,Death,17032664
0,,22.1,Decreased appetite,17032685
1,,22.1,Weight decreased,17032685
2,,22.1,Nausea,17032685
0,,22.1,Metastases to liver,17033015
0,2,22.1,Pain in extremity,16916695
0,6,22.1,Liver abscess,16916721
1,5,22.1,Rectal stenosis,16916721
2,6,22.1,Colonic fistula,16916721
0,6,22.1,Intentional product use issue,16916766
1,5,22.1,Death,16916766
0,6,22.1,Fournier^s gangrene,16916822
1,6,22.1,Palmar-plantar erythrodysaesthesia syndrome,16916822
2,6,22.1,Neurotoxicity,16916822
0,6,22.1,Tooth disorder,16916824
1,6,22.1,Neoplasm progression,16916824
2,6,22.1,Leukopenia,16916824
0,6,22.1,Pneumonia,16916892
1,6,22.1,Lung neoplasm malignant,16916892
0,3,22.1,Acute respiratory failure,16916990
1,3,22.1,Septic shock,16916990
2,3,22.1,Pneumonia,16916990
3,3,22.1,Hypoxia,16916990
4,3,22.1,Sepsis,16916990
5,1,22.1,Cardiac arrest,16916990
6,1,22.1,Oedema peripheral,16916990
0,2,22.1,Delirium,16917002
0,1,22.1,Alanine aminotransferase increased,16917005
0,5,22.1,Myocardial infarction,16917010
1,6,22.1,Decreased appetite,16917010
2,5,22.1,Sudden cardiac death,16917010
0,6,22.1,Bladder cancer,16917016
0,3,22.1,Cutaneous lupus erythematosus,16917053
0,5,22.1,Drug ineffective,16917068
1,5,22.1,Disease progression,16917068
0,1,22.1,Hypertransaminasaemia,16917086
1,1,22.1,Lacrimation increased,16917086
2,1,22.1,Pruritus,16917086
3,1,22.1,Skin fissures,16917086
4,1,22.1,Skin reaction,16917086
0,3,22.1,Fall,16917114
1,3,22.1,Femur fracture,16917114
0,5,22.1,Malignant neoplasm progression,16917138
0,5,22.1,Death,16917195
1,1,22.1,Asthenia,16917195
2,1,22.1,Feeding disorder,16917195
3,1,22.1,Lip swelling,16917195
4,1,22.1,Impaired driving ability,16917195
5,1,22.1,Trismus,16917195
6,1,22.1,Eye contusion,16917195
7,6,22.1,Pleural effusion,16917195
8,1,22.1,Fatigue,16917195
9,1,22.1,Nausea,16917195
10,6,22.1,Decreased appetite,16917195
11,1,22.1,Lethargy,16917195
12,1,22.1,Ascites,16917195
13,1,22.1,Diarrhoea,16917195
14,1,22.1,Gait inability,16917195
15,1,22.1,Apparent life threatening event,16917195
16,1,22.1,Lip discolouration,16917195
0,1,22.1,Hypotension,16917223
1,1,22.1,Dermatitis exfoliative generalised,16917223
2,1,22.1,Chest pain,16917223
3,1,22.1,Nausea,16917223
0,3,22.1,Body temperature decreased,16917250
1,3,22.1,Eosinophil percentage increased,16917250
2,3,22.1,Stress,16917250
3,3,22.1,Drug ineffective,16917250
4,3,22.1,Dyspnoea,16917250
5,3,22.1,Gingival bleeding,16917250
6,3,22.1,Malignant neoplasm progression,16917250
7,3,22.1,Stomatitis,16917250
8,3,22.1,Toothache,16917250
9,3,22.1,Alanine aminotransferase increased,16917250
10,3,22.1,Blood creatinine decreased,16917250
11,3,22.1,Blood pressure increased,16917250
12,3,22.1,Eosinophil count increased,16917250
13,3,22.1,Blood sodium decreased,16917250
14,3,22.1,Blood uric acid decreased,16917250
15,3,22.1,Cellulitis,16917250
16,3,22.1,Dizziness,16917250
17,3,22.1,Heart rate decreased,16917250
18,3,22.1,Heart rate increased,16917250
19,3,22.1,Injection site extravasation,16917250
20,3,22.1,Nausea,16917250
21,3,22.1,Peripheral swelling,16917250
22,3,22.1,Blood lactate dehydrogenase increased,16917250
23,3,22.1,Hypertension,16917250
24,3,22.1,Infusion related reaction,16917250
0,6,22.1,Arthropathy,16917254
1,6,22.1,Malignant neoplasm progression,16917254
0,6,22.1,Device related thrombosis,16917255
1,6,22.1,Neoplasm progression,16917255
0,2,22.1,Fall,16917277
0,1,22.1,Hypotension,16917278
1,1,22.1,Nausea,16917278
2,1,22.1,Oxygen saturation decreased,16917278
3,1,22.1,Flushing,16917278
4,1,22.1,Feeling hot,16917278
5,1,22.1,Heart rate decreased,16917278
6,1,22.1,Abdominal pain,16917278
0,1,22.1,Hypermagnesaemia,16917281
1,1,22.1,Hypomagnesaemia,16917281
0,4,22.1,Colitis,16917283
1,4,22.1,Abdominal discomfort,16917283
2,4,22.1,Febrile neutropenia,16917283
0,1,22.1,Disseminated intravascular coagulation,16917311
1,1,22.1,Condition aggravated,16917311
2,6,22.1,Thrombocytopenia,16917311
3,6,22.1,Treatment noncompliance,16917311
0,2,22.1,Cardiac failure chronic,16917315
1,6,22.1,Mitral valve incompetence,16917315
2,6,22.1,Acute pulmonary oedema,16917315
0,6,22.1,Pain in extremity,16917354
1,6,22.1,Visual impairment,16917354
2,6,22.1,Balance disorder,16917354
3,6,22.1,Vertigo,16917354
0,1,22.1,Metastatic uterine cancer,16917362
1,1,22.1,Drug interaction,16917362
0,6,22.1,Neutrophil count decreased,16917374
1,6,22.1,Vomiting,16917374
2,6,22.1,Nausea,16917374
0,6,22.1,Intestinal obstruction,16917433
0,1,22.1,Haemorrhage,16917438
1,6,22.1,Rectal haemorrhage,16917438
2,3,22.1,Anxiety,16917438
3,6,22.1,Product dose omission,16917438
4,3,22.1,Fatigue,16917438
5,6,22.1,Dehydration,16917438
6,3,22.1,Red blood cell count decreased,16917438
7,6,22.1,Colonoscopy abnormal,16917438
8,3,22.1,Anaemia,16917438
9,6,22.1,Gastrointestinal disorder,16917438
10,2,22.1,Blood pressure systolic increased,16917438
11,6,22.1,Platelet count decreased,16917438
12,6,22.1,Blood urine present,16917438
13,3,22.1,Back pain,16917438
14,3,22.1,Arthralgia,16917438
15,6,22.1,Inappropriate schedule of product administration,16917438
16,1,22.1,Thrombocytopenia,16917438
17,3,22.1,Dysphagia,16917438
0,6,22.1,Malignant neoplasm progression,16917439
1,6,22.1,Hypoaesthesia,16917439
2,1,22.1,Hypertension,16917439
3,3,22.1,Nausea,16917439
4,6,22.1,Drug intolerance,16917439
5,6,22.1,Abdominal pain,16917439
6,1,22.1,Constipation,16917439
7,6,22.1,Paraesthesia,16917439
8,6,22.1,Lymphoedema,16917439
0,3,22.1,Platelet count decreased,16917440
1,6,22.1,Nausea,16917440
2,1,22.1,Carbohydrate antigen 125 increased,16917440
3,6,22.1,Gastric disorder,16917440
4,6,22.1,Inappropriate schedule of product administration,16917440
5,6,22.1,Therapeutic product effect decreased,16917440
6,3,22.1,Ovarian cancer recurrent,16917440
0,6,22.1,Angioedema,16917442
1,3,22.1,Mucosal inflammation,16917442
2,6,22.1,Fatigue,16917442
3,3,22.1,Depression,16917442
4,6,22.1,Constipation,16917442
5,6,22.1,Oropharyngeal pain,16917442
6,6,22.1,Red blood cell count decreased,16917442
7,6,22.1,Mouth swelling,16917442
8,6,22.1,Proteinuria,16917442
9,6,22.1,Disease progression,16917442
10,6,22.1,Platelet count decreased,16917442
11,6,22.1,Intentional product misuse,16917442
12,6,22.1,Intestinal obstruction,16917442
13,6,22.1,Blood pressure increased,16917442
14,2,22.1,Nausea,16917442
15,6,22.1,Inappropriate schedule of product administration,16917442
16,6,22.1,Alopecia,16917442
17,6,22.1,White blood cell count decreased,16917442
18,6,22.1,Upper-airway cough syndrome,16917442
0,6,22.1,Clostridium difficile infection,16917454
0,1,22.1,Pruritus,16917476
1,1,22.1,Flushing,16917476
0,1,22.1,Off label use,16917481
1,1,22.1,Colitis,16917481
2,1,22.1,Recall phenomenon,16917481
0,2,22.1,Delirium,16917484
1,2,22.1,Cognitive disorder,16917484
2,2,22.1,Memory impairment,16917484
0,6,22.1,Neutropenia,16917485
1,6,22.1,Myalgia,16917485
2,6,22.1,Dyspnoea,16917485
3,6,22.1,Fatigue,16917485
4,6,22.1,Decreased appetite,16917485
5,6,22.1,Nausea,16917485
0,6,22.1,Nausea,16917486
1,6,22.1,Pruritus,16917486
2,6,22.1,Dyspnoea,16917486
3,6,22.1,Flushing,16917486
4,6,22.1,Product use issue,16917486
0,6,22.1,Vomiting,16917488
1,6,22.1,Clostridium difficile infection,16917488
2,6,22.1,Diarrhoea,16917488
0,1,22.1,Pruritus,16917510
1,1,22.1,Urticaria,16917510
2,1,22.1,Flushing,16917510
3,1,22.1,Nausea,16917510
4,1,22.1,Obstructive airways disorder,16917510
5,1,22.1,Vomiting,16917510
0,1,22.1,Hypersensitivity vasculitis,16917511
0,3,22.1,Flushing,16917514
1,3,22.1,Throat irritation,16917514
2,3,22.1,Infusion related reaction,16917514
3,3,22.1,Pharyngeal oedema,16917514
4,3,22.1,Swollen tongue,16917514
5,3,22.1,Back pain,16917514
6,3,22.1,Erythema,16917514
7,3,22.1,Pruritus,16917514
0,1,22.1,Pruritus,16917518
1,1,22.1,Anaphylactic reaction,16917518
2,1,22.1,Rash,16917518
3,1,22.1,Palatal swelling,16917518
4,1,22.1,Erythema,16917518
0,6,22.1,Anaemia,16917521
1,6,22.1,Wrong technique in product usage process,16917521
2,6,22.1,Metastases to lung,16917521
3,6,22.1,Neurotoxicity,16917521
4,6,22.1,Metastases to liver,16917521
5,6,22.1,Metastases to bone,16917521
6,6,22.1,Breast cancer,16917521
7,6,22.1,Metastases to lymph nodes,16917521
8,6,22.1,Malignant neoplasm progression,16917521
9,6,22.1,Transaminases abnormal,16917521
0,1,22.1,Encephalopathy,16917569
1,1,22.1,Febrile neutropenia,16917569
0,6,22.1,Bone disorder,16917574
0,3,22.1,Thrombocytopenia,16917587
1,3,22.1,Anaemia,16917587
0,6,22.1,Neoplasm progression,16917592
1,6,22.1,Hip arthroplasty,16917592
0,1,22.1,Prostatic specific antigen increased,16917599
0,1,22.1,Osteonecrosis of jaw,16917619
0,2,22.1,Haemophagocytic lymphohistiocytosis,16917651
1,1,22.1,Chronic obstructive pulmonary disease,16917651
2,2,22.1,Pneumonia,16917651
3,1,22.1,Bronchitis,16917651
0,5,22.1,Cholestasis,16917658
0,1,22.1,Oxygen saturation decreased,16917684
1,1,22.1,Hyperhidrosis,16917684
2,1,22.1,Blood pressure immeasurable,16917684
3,1,22.1,Dyspnoea,16917684
4,1,22.1,Chest pain,16917684
0,3,22.1,Systemic lupus erythematosus,16917702
0,6,22.1,Biliary cancer metastatic,16917712
1,1,22.1,Off label use,16917712
0,6,22.1,Leukoencephalopathy,16917740
1,6,22.1,Central nervous system neoplasm,16917740
2,6,22.1,Quadriplegia,16917740
0,6,22.1,Haemorrhage,16917763
1,6,22.1,Constipation,16917763
2,6,22.1,Diarrhoea,16917763
3,6,22.1,Hypertension,16917763
4,6,22.1,Rash,16917763
5,6,22.1,Vomiting,16917763
6,6,22.1,Hepatic function abnormal,16917763
7,6,22.1,Proteinuria,16917763
8,6,22.1,Dry skin,16917763
9,6,22.1,Decreased appetite,16917763
10,6,22.1,Paronychia,16917763
0,2,22.1,Blood alkaline phosphatase increased,16917787
0,3,22.1,Insomnia,16917829
1,3,22.1,Fatigue,16917829
2,3,22.1,Loss of consciousness,16917829
3,3,22.1,Malaise,16917829
4,3,22.1,Muscle spasms,16917829
0,6,22.1,Intentional product use issue,16917848
1,5,22.1,Thrombophlebitis migrans,16917848
2,5,22.1,Acute myocardial infarction,16917848
3,6,22.1,Off label use,16917848
0,5,22.1,Drug ineffective,16917855
0,1,22.1,Anaphylactoid reaction,16917857
0,1,22.1,Erythema,16917864
1,1,22.1,Infusion site reaction,16917864
0,2,22.1,Ulcer,16917899
1,1,22.1,Haematemesis,16917899
2,2,22.1,Chest pain,16917899
3,1,22.1,Stoma site haemorrhage,16917899
0,6,22.1,Therapeutic response decreased,16917922
1,6,22.1,Hormone-refractory prostate cancer,16917922
2,6,22.1,Drug interaction,16917922
0,2,22.1,Anaemia,16917951
0,6,22.1,Recalled product,16917993
1,1,22.1,Hypocalcaemia,16917993
2,3,22.1,Off label use,16917993
0,1,22.1,Increased tendency to bruise,16917998
1,1,22.1,Hypersensitivity,16917998
0,6,22.1,Neutrophil count decreased,16918027
1,5,22.1,Oesophageal varices haemorrhage,16918027
2,6,22.1,Hypoxic-ischaemic encephalopathy,16918027
0,2,22.1,Bone marrow failure,16918029
0,6,22.1,Transaminases increased,16918083
0,6,22.1,Anaemia,16918092
0,3,22.1,Fatigue,16918122
1,1,22.1,Rash maculo-papular,16918122
2,1,22.1,Diarrhoea,16918122
3,1,22.1,Acute kidney injury,16918122
0,3,22.1,Palmar-plantar erythrodysaesthesia syndrome,16918136
0,2,22.1,Liver disorder,16918181
0,3,22.1,Acute hepatic failure,16918183
1,6,22.1,Off label use,16918183
2,3,22.1,Transaminases increased,16918183
3,3,22.1,Blood bilirubin increased,16918183
4,3,22.1,Platelet count decreased,16918183
0,6,22.1,Off label use,16918202
1,6,22.1,Blood prolactin increased,16918202
2,6,22.1,Product use in unapproved indication,16918202
0,2,22.1,Anaemia,16918250
0,2,22.1,Anaemia,16918256
0,6,22.1,Hypertriglyceridaemia,16918258
1,6,22.1,Gamma-glutamyltransferase increased,16918258
2,6,22.1,Alanine aminotransferase increased,16918258
3,6,22.1,Blood alkaline phosphatase increased,16918258
0,4,22.1,Pathological fracture,16918263
1,2,22.1,Plasmacytoma,16918263
0,5,22.1,Death,16918266
0,2,22.1,Immune thrombocytopenic purpura,16918334
0,6,22.1,Glomerulonephritis acute,16918364
1,6,22.1,Disease progression,16918364
2,6,22.1,Erysipelas,16918364
3,6,22.1,Thrombotic microangiopathy,16918364
0,1,22.1,Cachexia,16918397
0,3,22.1,Xerosis,16918411
1,3,22.1,Acne,16918411
0,6,22.1,Alopecia,16918413
1,6,22.1,Anaemia,16918413
2,6,22.1,Asthenia,16918413
3,6,22.1,Amenorrhoea,16918413
4,6,22.1,Myalgia,16918413
0,6,22.1,Pleural effusion,16918422
1,6,22.1,Metastases to lung,16918422
2,6,22.1,Aplastic anaemia,16918422
0,6,22.1,Cell-mediated immune deficiency,16918426
1,2,22.1,Pneumocystis jirovecii pneumonia,16918426
2,6,22.1,Rash,16918426
0,2,22.1,Progressive multifocal leukoencephalopathy,16918447
0,3,22.1,Cutaneous lupus erythematosus,16918471
0,6,22.1,Pathological fracture,16918472
1,2,22.1,Immune-mediated hepatitis,16918472
0,1,22.1,Hepatocellular injury,16918525
0,6,22.1,Peripheral swelling,16918550
1,6,22.1,Erythema,16918550
0,5,22.1,Sudden death,16918560
0,1,22.1,Anaphylactic shock,16918574
1,5,22.1,Death,16918574
0,2,22.1,Immune-mediated pneumonitis,16918637
0,6,22.1,Bone marrow granuloma,16918664
1,6,22.1,Disseminated Bacillus Calmette-Guerin infection,16918664
0,2,22.1,Uveitis,16918686
1,2,22.1,Retinal detachment,16918686
2,1,22.1,Adrenal insufficiency,16918686
0,6,22.1,Ureteral neoplasm,16918688
1,6,22.1,Incorrect dose administered,16918688
2,6,22.1,Bladder cancer recurrent,16918688
3,6,22.1,Product availability issue,16918688
0,6,22.1,Bladder tamponade,16918700
1,6,22.1,Blood creatinine increased,16918700
2,6,22.1,Blood urine present,16918700
0,6,22.1,Epistaxis,16918706
1,3,22.1,Oropharyngeal pain,16918706
2,3,22.1,Hypertension,16918706
3,3,22.1,Decreased appetite,16918706
4,3,22.1,Pruritus,16918706
5,6,22.1,Pain in extremity,16918706
0,3,22.1,Angina bullosa haemorrhagica,16918716
0,6,22.1,Clostridium difficile infection,16918748
0,3,22.1,Decreased appetite,16918750
0,1,22.1,Lower respiratory tract infection,16918782
0,6,22.1,Performance status decreased,16918801
1,6,22.1,Drug tolerance,16918801
0,5,22.1,Marasmus,16918864
1,6,22.1,Prescribed underdose,16918864
0,6,22.1,Rash,16918874
1,1,22.1,Hyperglycaemia,16918874
2,6,22.1,Nausea,16918874
3,6,22.1,Vomiting,16918874
4,6,22.1,Blood creatinine increased,16918874
0,6,22.1,White blood cell count decreased,16918886
1,1,22.1,Vomiting,16918886
2,6,22.1,Syncope,16918886
3,6,22.1,Dizziness,16918886
4,1,22.1,Diarrhoea,16918886
5,6,22.1,Product use issue,16918886
0,6,22.1,Joint stiffness,16918922
1,2,22.1,Atrial fibrillation,16918922
2,3,22.1,Weight increased,16918922
3,3,22.1,Post procedural complication,16918922
4,6,22.1,Pain,16918922
5,6,22.1,Fatigue,16918922
0,6,22.1,Gastrointestinal disorder,16918936
1,6,22.1,Stomatitis,16918936
2,6,22.1,Fatigue,16918936
0,3,22.1,Asthenia,16918942
1,1,22.1,Neutropenia,16918942
2,3,22.1,Cough,16918942
3,3,22.1,Influenza like illness,16918942
0,2,22.1,Hypocalcaemia,16918984
0,6,22.1,Hormone-refractory prostate cancer,16918985
0,6,22.1,Off label use,16918997
1,1,22.1,Nasopharyngitis,16918997
2,6,22.1,Product use issue,16918997
3,6,22.1,Stomatitis,16918997
4,6,22.1,Fatigue,16918997
0,2,22.1,White blood cell count decreased,16918999
0,6,22.1,Dry mouth,16919002
1,6,22.1,Thirst,16919002
2,6,22.1,Oropharyngeal pain,16919002
3,6,22.1,Sleep disorder,16919002
4,6,22.1,Product dose omission,16919002
5,6,22.1,Dysphagia,16919002
6,6,22.1,Diarrhoea,16919002
7,6,22.1,Nail growth abnormal,16919002
8,6,22.1,Alopecia,16919002
9,6,22.1,Skin odour abnormal,16919002
10,6,22.1,Fatigue,16919002
0,6,22.1,Fatigue,16919006
1,6,22.1,Taste disorder,16919006
0,6,22.1,Dyspnoea,16919008
1,6,22.1,White blood cell count decreased,16919008
2,6,22.1,Malaise,16919008
0,6,22.1,White blood cell count abnormal,16919011
0,6,22.1,Dermatitis acneiform,16919020
1,6,22.1,Constipation,16919020
0,6,22.1,Abdominal pain,16919029
1,6,22.1,Abdominal hernia,16919029
0,1,22.1,Abdominal distension,16919049
0,6,22.1,Swelling,16919051
1,6,22.1,Rash,16919051
2,6,22.1,Infection,16919051
3,6,22.1,Product packaging quantity issue,16919051
4,6,22.1,Ocular hyperaemia,16919051
5,6,22.1,Oedema peripheral,16919051
0,1,22.1,Leukopenia,16919057
1,1,22.1,Neutrophil count decreased,16919057
2,1,22.1,Febrile infection,16919057
3,1,22.1,Leukopenia,16919057
4,1,22.1,Nausea,16919057
5,1,22.1,Pneumonia,16919057
6,1,22.1,C-reactive protein increased,16919057
7,6,22.1,Leukopenia,16919057
8,1,22.1,Nausea,16919057
9,6,22.1,Neutropenia,16919057
0,2,22.1,Hepatitis acute,16919089
0,5,22.1,Death,16919097
1,1,22.1,Nausea,16919097
2,6,22.1,Underdose,16919097
3,6,22.1,Brain operation,16919097
4,1,22.1,Diarrhoea,16919097
0,6,22.1,Asthenia,16919098
1,6,22.1,Fatigue,16919098
2,5,22.1,Death,16919098
3,6,22.1,Abdominal discomfort,16919098
0,3,22.1,Nausea,16919099
1,6,22.1,Dehydration,16919099
2,6,22.1,Diarrhoea,16919099
3,6,22.1,Fatigue,16919099
4,6,22.1,Asthenia,16919099
5,5,22.1,Death,16919099
6,6,22.1,Vomiting,16919099
0,6,22.1,Dehydration,16919118
1,6,22.1,Electrolyte imbalance,16919118
2,3,22.1,Hyperhidrosis,16919118
3,6,22.1,Vomiting,16919118
4,3,22.1,Malignant neoplasm progression,16919118
5,6,22.1,Product use in unapproved indication,16919118
6,3,22.1,Ovarian cancer,16919118
7,6,22.1,Malaise,16919118
8,3,22.1,Chills,16919118
9,3,22.1,Diarrhoea,16919118
10,6,22.1,Nausea,16919118
0,3,22.1,Neoplasm progression,16919144
0,6,22.1,General physical health deterioration,16919145
0,6,22.1,Dyspnoea,16919181
0,,22.1,Blood alkaline phosphatase increased,16919205
1,1,22.1,Oropharyngeal pain,16919205
2,1,22.1,Malaise,16919205
3,1,22.1,Decreased appetite,16919205
4,1,22.1,Hepatic function abnormal,16919205
5,5,22.1,Rectal cancer,16919205
6,1,22.1,Jaundice,16919205
7,1,22.1,Blood bilirubin increased,16919205
8,1,22.1,Pyrexia,16919205
0,6,22.1,Fatigue,16919210
1,6,22.1,Hypersomnia,16919210
0,5,22.1,Death,16919236
0,6,22.1,Neoplasm progression,16919247
1,6,22.1,Pleural effusion,16919247
0,3,22.1,Hair texture abnormal,16919262
1,3,22.1,Madarosis,16919262
2,3,22.1,Alopecia,16919262
3,3,22.1,Hair colour changes,16919262
4,3,22.1,Hair disorder,16919262
0,6,22.1,Headache,16919270
0,6,22.1,Neuropathy peripheral,16919287
1,6,22.1,Aphthous ulcer,16919287
2,6,22.1,Musculoskeletal discomfort,16919287
3,6,22.1,Constipation,16919287
4,2,22.1,Headache,16919287
0,6,22.1,Off label use,16919299
1,5,22.1,Malignant neoplasm progression,16919299
2,2,22.1,Interstitial lung disease,16919299
0,5,22.1,Death,16919305
0,6,22.1,Diaphragm muscle weakness,16919314
1,6,22.1,Mononeuropathy,16919314
0,3,22.1,Neuropathy peripheral,16919330
0,6,22.1,Pyrexia,16919365
1,6,22.1,Influenza like illness,16919365
2,6,22.1,Pruritus,16919365
3,6,22.1,Throat irritation,16919365
4,6,22.1,Dry skin,16919365
5,3,22.1,Stomatitis,16919365
6,6,22.1,Fatigue,16919365
7,6,22.1,Gingival pain,16919365
0,6,22.1,Fatigue,16919372
1,6,22.1,Alopecia,16919372
0,6,22.1,Transfusion,16919378
1,6,22.1,Blood disorder,16919378
2,6,22.1,Diarrhoea,16919378
0,5,22.1,Diarrhoea,16919401
1,6,22.1,Product use in unapproved indication,16919401
0,3,22.1,Blood pressure increased,16919428
1,6,22.1,Pain in extremity,16919428
2,6,22.1,Sluggishness,16919428
3,6,22.1,Dysphagia,16919428
4,6,22.1,Vomiting,16919428
5,6,22.1,Weight decreased,16919428
6,6,22.1,Pulmonary oedema,16919428
7,6,22.1,Asthenia,16919428
8,3,22.1,Decreased appetite,16919428
9,6,22.1,Decubitus ulcer,16919428
10,3,22.1,Abdominal pain,16919428
11,6,22.1,Constipation,16919428
12,6,22.1,Peripheral swelling,16919428
13,6,22.1,Malaise,16919428
14,6,22.1,Increased upper airway secretion,16919428
15,6,22.1,Haemoglobin decreased,16919428
16,6,22.1,Musculoskeletal stiffness,16919428
17,6,22.1,Dyspnoea,16919428
18,6,22.1,Gastric ulcer,16919428
19,3,22.1,Fatigue,16919428
0,6,22.1,Appendicitis,16919476
1,1,22.1,Fatigue,16919476
2,1,22.1,Decreased appetite,16919476
0,1,22.1,Lower respiratory tract infection,16919527
1,4,22.1,Nausea,16919527
2,4,22.1,Lethargy,16919527
3,4,22.1,Abdominal pain upper,16919527
4,4,22.1,Influenza,16919527
5,4,22.1,Pyrexia,16919527
6,4,22.1,Pneumonia,16919527
7,1,22.1,Body temperature increased,16919527
0,6,22.1,Anaemia,16919557
1,6,22.1,Neutropenia,16919557
2,6,22.1,Decreased appetite,16919557
3,6,22.1,Thrombocytopenia,16919557
0,3,22.1,Anxiety,16919570
1,3,22.1,Musculoskeletal chest pain,16919570
2,6,22.1,Pain,16919570
3,3,22.1,Muscular weakness,16919570
4,3,22.1,Headache,16919570
5,3,22.1,Hyperhidrosis,16919570
6,3,22.1,General physical health deterioration,16919570
7,6,22.1,Chest injury,16919570
8,3,22.1,Decreased appetite,16919570
9,3,22.1,Fall,16919570
10,3,22.1,Jaundice,16919570
11,3,22.1,Insomnia,16919570
12,6,22.1,Limb injury,16919570
13,3,22.1,Vision blurred,16919570
14,6,22.1,Chromaturia,16919570
15,3,22.1,Dizziness,16919570
16,3,22.1,Pain in extremity,16919570
0,1,22.1,Nausea,16919617
1,6,22.1,Pleural effusion,16919617
2,1,22.1,Vomiting,16919617
3,1,22.1,Abdominal discomfort,16919617
4,1,22.1,Dry eye,16919617
5,6,22.1,Lymphoedema,16919617
6,6,22.1,Skin abrasion,16919617
7,1,22.1,Stomatitis,16919617
0,6,22.1,Nausea,16919619
1,2,22.1,Back pain,16919619
2,6,22.1,Dry eye,16919619
3,2,22.1,Back injury,16919619
4,2,22.1,Gingival pain,16919619
5,6,22.1,Dry throat,16919619
6,6,22.1,Nasal dryness,16919619
7,3,22.1,Weight decreased,16919619
8,6,22.1,Fall,16919619
9,6,22.1,Allergic cough,16919619
10,6,22.1,Muscular weakness,16919619
11,3,22.1,Decreased appetite,16919619
12,6,22.1,Asthenia,16919619
13,3,22.1,Fatigue,16919619
14,6,22.1,Insomnia,16919619
15,2,22.1,Mobility decreased,16919619
0,4,22.1,Peripheral sensory neuropathy,16919625
0,,22.1,Death,16919633
0,1,22.1,Hepatitis,16919668
0,1,22.1,Lacrimation increased,16919685
1,1,22.1,Erythema,16919685
2,1,22.1,Rash macular,16919685
0,,22.1,Death,16919789
0,2,22.1,Interstitial lung disease,16919812
0,3,22.1,Colon neoplasm,16919824
0,6,22.1,Arthropathy,16919832
1,6,22.1,Neoplasm progression,16919832
0,6,22.1,Ascites,16919898
1,6,22.1,Pleural effusion,16919898
2,6,22.1,Pseudocirrhosis,16919898
3,2,22.1,Hepatic encephalopathy,16919898
0,5,22.1,Prostate cancer,16919905
0,2,22.1,Hypoxia,16919973
0,1,22.1,Eyelid ptosis,16919977
1,6,22.1,Malignant neoplasm progression,16919977
0,,22.1,Disease progression,16920015
0,,22.1,Disease progression,16920020
0,6,22.1,Adverse event,16920035
0,6,22.1,Road traffic accident,16920054
1,6,22.1,Taste disorder,16920054
2,6,22.1,Metastases to meninges,16920054
0,2,22.1,Hallucination,16920069
1,2,22.1,Fall,16920069
2,2,22.1,Hypopnoea,16920069
3,2,22.1,Confusional state,16920069
4,2,22.1,Balance disorder,16920069
5,2,22.1,Dizziness,16920069
6,2,22.1,Amnesia,16920069
0,6,22.1,Neurotoxicity,16920084
1,6,22.1,Disease progression,16920084
2,2,22.1,Paraesthesia,16920084
0,,22.1,Neuropathy peripheral,16920099
1,,22.1,Condition aggravated,16920099
2,,22.1,Abdominal pain upper,16920099
3,,22.1,Epistaxis,16920099
0,6,22.1,Neutrophil count decreased,16920152
1,6,22.1,Platelet count decreased,16920152
0,6,22.1,Toxicity to various agents,16920210
1,6,22.1,Product use in unapproved indication,16920210
2,6,22.1,Mucosal inflammation,16920210
0,1,22.1,Neutropenia,16920240
1,6,22.1,Neutropenia,16920240
0,,22.1,Erythema,16920265
1,,22.1,Skin exfoliation,16920265
2,,22.1,Pneumonia,16920265
0,6,22.1,Neutropenia,16920269
0,,22.1,Infection,16920271
1,,22.1,Diarrhoea,16920271
0,6,22.1,Sinus tachycardia,16920294
1,6,22.1,Hypoxia,16920294
2,6,22.1,Neutrophil count decreased,16920294
3,3,22.1,Pulmonary hypertension,16920294
4,6,22.1,Macrophages increased,16920294
5,3,22.1,Pneumonitis,16920294
6,6,22.1,Eosinophil count decreased,16920294
7,6,22.1,Lymphocyte count increased,16920294
8,6,22.1,Tricuspid valve incompetence,16920294
0,5,22.1,Alveolitis,16920329
1,5,22.1,Back pain,16920329
2,5,22.1,Dyspnoea,16920329
3,5,22.1,Fatigue,16920329
4,5,22.1,Gout,16920329
5,5,22.1,Interstitial lung disease,16920329
6,5,22.1,Joint stiffness,16920329
7,5,22.1,Nasopharyngitis,16920329
8,5,22.1,Nausea,16920329
9,5,22.1,Proteinuria,16920329
10,5,22.1,Radiculopathy,16920329
11,5,22.1,Vomiting,16920329
12,5,22.1,Antineutrophil cytoplasmic antibody positive,16920329
13,5,22.1,Arthralgia,16920329
14,5,22.1,Dizziness,16920329
15,5,22.1,Granulomatosis with polyangiitis,16920329
16,5,22.1,Intervertebral disc protrusion,16920329
17,5,22.1,Malignant melanoma in situ,16920329
18,5,22.1,Pulmonary granuloma,16920329
19,5,22.1,Death,16920329
20,5,22.1,Palpitations,16920329
21,5,22.1,Pyrexia,16920329
22,5,22.1,Disease recurrence,16920329
23,5,22.1,Hypoaesthesia,16920329
24,5,22.1,Neoplasm,16920329
25,5,22.1,Rash,16920329
26,5,22.1,Arteriosclerosis,16920329
27,5,22.1,Acne,16920329
28,5,22.1,C-reactive protein increased,16920329
29,5,22.1,Pneumonia,16920329
30,5,22.1,Weight increased,16920329
31,5,22.1,Drug hypersensitivity,16920329
32,5,22.1,Neutropenia,16920329
33,5,22.1,Steroid diabetes,16920329
34,5,22.1,Blood creatinine increased,16920329
35,5,22.1,Neutrophil count decreased,16920329
36,5,22.1,Weight decreased,16920329
0,1,22.1,Blood creatinine increased,16920331
1,1,22.1,Pneumonia,16920331
2,1,22.1,Ileal stenosis,16920331
3,6,22.1,General physical health deterioration,16920331
4,1,22.1,Anaemia,16920331
5,3,22.1,Hyperkalaemia,16920331
6,1,22.1,Urinary retention,16920331
0,6,22.1,Diarrhoea,16920377
1,6,22.1,Decreased appetite,16920377
2,6,22.1,Vomiting,16920377
3,5,22.1,Intestinal obstruction,16920377
0,3,22.1,Dehydration,16920498
1,3,22.1,Enteritis,16920498
2,5,22.1,Death,16920498
3,3,22.1,Nausea,16920498
4,3,22.1,Pancytopenia,16920498
5,5,22.1,Neutropenic sepsis,16920498
6,3,22.1,Oral pain,16920498
7,3,22.1,Vomiting,16920498
8,3,22.1,Mucosal inflammation,16920498
9,3,22.1,Diarrhoea,16920498
0,6,22.1,Intestinal obstruction,16920517
1,2,22.1,Malignant neoplasm progression,16920517
0,5,22.1,Death,16920593
0,6,22.1,Headache,16920600
1,6,22.1,Neoplasm progression,16920600
2,2,22.1,Insomnia,16920600
3,6,22.1,Hypertension,16920600
4,6,22.1,Thrombocytopenia,16920600
0,6,22.1,Inflammation,16920615
1,6,22.1,Blood count abnormal,16920615
2,6,22.1,Hypoaesthesia,16920615
3,6,22.1,Arthritis,16920615
4,6,22.1,Neuralgia,16920615
0,6,22.1,Lip pruritus,16920619
1,6,22.1,Feeling of body temperature change,16920619
2,6,22.1,Lip dry,16920619
3,1,22.1,Epistaxis,16920619
4,6,22.1,Ageusia,16920619
5,6,22.1,Fatigue,16920619
6,6,22.1,White blood cell count decreased,16920619
7,6,22.1,Taste disorder,16920619
8,6,22.1,Decreased appetite,16920619
0,6,22.1,Nausea,16920622
1,6,22.1,Constipation,16920622
2,6,22.1,Tooth disorder,16920622
3,6,22.1,White blood cell count decreased,16920622
0,6,22.1,Platelet count decreased,16920625
1,6,22.1,Neutrophil count decreased,16920625
2,6,22.1,White blood cell count decreased,16920625
0,6,22.1,Fatigue,16920627
1,6,22.1,Asthenia,16920627
0,2,22.1,Nausea,16920628
1,1,22.1,Poor quality product administered,16920628
2,1,22.1,Product physical issue,16920628
0,3,22.1,Neutropenia,16920664
1,1,22.1,Clostridium difficile infection,16920664
2,1,22.1,Syncope,16920664
3,1,22.1,Body temperature increased,16920664
4,1,22.1,Swelling face,16920664
5,1,22.1,Diarrhoea,16920664
6,6,22.1,Electrocardiogram QT prolonged,16920664
7,1,22.1,Diarrhoea,16920664
8,3,22.1,Infection,16920664
0,3,22.1,Anaemia,16920677
1,3,22.1,Fatigue,16920677
2,3,22.1,Bone neoplasm,16920677
3,3,22.1,Lung neoplasm,16920677
4,3,22.1,Neoplasm,16920677
0,1,22.1,Neutropenic infection,16920694
0,3,22.1,Diarrhoea,16920712
1,1,22.1,Cystitis,16920712
2,3,22.1,Bone pain,16920712
3,3,22.1,Alopecia,16920712
4,3,22.1,Sleep disorder,16920712
5,3,22.1,Lymphoedema,16920712
6,6,22.1,Malignant pleural effusion,16920712
7,3,22.1,Dyspnoea exertional,16920712
8,4,22.1,Dyspnoea,16920712
0,6,22.1,Tricuspid valve incompetence,16920717
1,6,22.1,Lymphocyte count increased,16920717
2,3,22.1,Pulmonary hypertension,16920717
3,6,22.1,Diastolic dysfunction,16920717
4,3,22.1,Pneumonitis,16920717
5,6,22.1,Tachycardia,16920717
6,6,22.1,Bronchial disorder,16920717
7,6,22.1,Neutrophil count decreased,16920717
8,6,22.1,Interstitial lung disease,16920717
9,6,22.1,Pulmonary embolism,16920717
10,6,22.1,Hypoxia,16920717
0,6,22.1,Headache,16920721
1,6,22.1,Head injury,16920721
2,6,22.1,Chest pain,16920721
3,6,22.1,Inappropriate schedule of product administration,16920721
4,6,22.1,Fall,16920721
0,3,22.1,Weight decreased,16920750
1,1,22.1,Vomiting,16920750
2,6,22.1,Malignant neoplasm progression,16920750
3,6,22.1,Lymphadenopathy,16920750
4,1,22.1,Constipation,16920750
5,2,22.1,Fatigue,16920750
6,6,22.1,Heart rate increased,16920750
7,1,22.1,Malaise,16920750
8,2,22.1,Asthenia,16920750
9,1,22.1,Blood pressure increased,16920750
10,6,22.1,Insomnia,16920750
11,1,22.1,Fluid intake reduced,16920750
12,6,22.1,Hernia,16920750
13,1,22.1,Loss of personal independence in daily activities,16920750
14,1,22.1,Platelet count decreased,16920750
15,2,22.1,Abdominal pain upper,16920750
16,2,22.1,Decreased appetite,16920750
17,2,22.1,Nausea,16920750
0,2,22.1,Back pain,16920752
1,2,22.1,Migraine,16920752
2,2,22.1,Vomiting,16920752
3,2,22.1,Musculoskeletal pain,16920752
4,2,22.1,Gastritis,16920752
5,2,22.1,Decreased appetite,16920752
6,2,22.1,Nausea,16920752
7,2,22.1,Depressed mood,16920752
0,3,22.1,Renal disorder,16920813
0,6,22.1,Skin disorder,16920840
1,6,22.1,IgA nephropathy,16920840
0,3,22.1,Blood alkaline phosphatase increased,16920856
1,4,22.1,Gastric haemorrhage,16920856
2,4,22.1,Decreased appetite,16920856
0,6,22.1,Fatigue,16920868
0,6,22.1,Anaemia,16920869
1,6,22.1,Thrombocytopenia,16920869
0,6,22.1,Tubulointerstitial nephritis,16920886
0,6,22.1,Constipation,16920889
1,6,22.1,Diabetes mellitus,16920889
2,1,22.1,Vomiting,16920889
0,1,22.1,Nausea,16920892
1,1,22.1,Nasopharyngitis,16920892
2,1,22.1,Product use in unapproved indication,16920892
3,1,22.1,Vomiting,16920892
4,1,22.1,Febrile neutropenia,16920892
0,1,22.1,Dysphonia,16920893
1,1,22.1,Choking sensation,16920893
2,1,22.1,Lacrimation increased,16920893
3,1,22.1,Erythema of eyelid,16920893
0,1,22.1,Hepatic function abnormal,16920911
1,1,22.1,Myasthenia gravis,16920911
2,6,22.1,Myositis,16920911
0,6,22.1,Neuropathy peripheral,16920928
0,1,22.1,Neuropathy peripheral,16920948
1,1,22.1,Tremor,16920948
2,1,22.1,Urosepsis,16920948
3,1,22.1,Bacterial test positive,16920948
4,1,22.1,Hypersensitivity,16920948
5,1,22.1,Anaphylactic reaction,16920948
6,1,22.1,Cystitis noninfective,16920948
7,1,22.1,Malaise,16920948
8,1,22.1,Fatigue,16920948
9,1,22.1,Diarrhoea,16920948
10,3,22.1,Defaecation urgency,16920948
11,3,22.1,Tendonitis,16920948
12,1,22.1,Rash,16920948
13,1,22.1,Urinary tract infection,16920948
14,3,22.1,Palmar erythema,16920948
15,1,22.1,Hypertension,16920948
16,1,22.1,Mucosal inflammation,16920948
17,1,22.1,Dyspnoea,16920948
0,6,22.1,Malignant neoplasm progression,16920969
1,6,22.1,Breast cancer stage II,16920969
0,2,22.1,Anaemia,16921035
1,1,22.1,Pleural effusion,16921035
2,5,22.1,General physical health deterioration,16921035
0,1,22.1,Stomatitis,16921081
1,6,22.1,Product use in unapproved indication,16921081
2,1,22.1,Immune-mediated enterocolitis,16921081
0,6,22.1,Hyperglycaemia,16921095
0,5,22.1,Cardiac failure,16921096
0,5,22.1,Malignant neoplasm progression,16921178
0,3,22.1,Non-small cell lung cancer,16921206
0,6,22.1,Psychological trauma,16921288
1,3,22.1,Alopecia,16921288
0,6,22.1,Psychological trauma,16921297
1,2,22.1,Alopecia,16921297
0,6,22.1,Psychological trauma,16921301
1,2,22.1,Alopecia,16921301
0,2,22.1,Alopecia,16921304
0,6,22.1,Psychological trauma,16921309
1,6,22.1,Pain,16921309
2,2,22.1,Alopecia,16921309
3,6,22.1,Emotional distress,16921309
4,6,22.1,Impaired quality of life,16921309
5,6,22.1,Anxiety,16921309
0,2,22.1,Alopecia,16921317
1,6,22.1,Psychological trauma,16921317
0,2,22.1,Alopecia,16921318
1,6,22.1,Anxiety,16921318
2,6,22.1,Impaired quality of life,16921318
3,6,22.1,Pain,16921318
4,6,22.1,Psychological trauma,16921318
5,6,22.1,Emotional distress,16921318
0,3,22.1,Alopecia,16921319
1,6,22.1,Psychological trauma,16921319
0,6,22.1,Fatigue,16921410
1,6,22.1,General physical health deterioration,16921410
2,6,22.1,Sexual dysfunction,16921410
0,2,22.1,Interstitial lung disease,16921419
1,1,22.1,Adrenal insufficiency,16921419
2,1,22.1,Hyponatraemia,16921419
3,2,22.1,Steroid diabetes,16921419
4,6,22.1,Malignant neoplasm progression,16921419
5,1,22.1,Hypopituitarism,16921419
0,3,22.1,Thrombocytopenia,16921430
1,1,22.1,Disseminated intravascular coagulation,16921430
2,6,22.1,Treatment noncompliance,16921430
0,1,22.1,Staphylococcal infection,16921439
1,1,22.1,Vascular device infection,16921439
2,3,22.1,Stevens-Johnson syndrome,16921439
0,6,22.1,Malignant neoplasm progression,16921441
1,1,22.1,Syncope,16921441
0,1,22.1,Febrile neutropenia,16921443
0,6,22.1,Osteonecrosis of jaw,16921488
1,6,22.1,Bone disorder,16921488
2,6,22.1,Arthralgia,16921488
3,6,22.1,Confusional state,16921488
0,6,22.1,Product use in unapproved indication,16921501
1,6,22.1,Toxicity to various agents,16921501
2,6,22.1,Failure to thrive,16921501
0,5,22.1,Cerebellar stroke,16921502
0,1,22.1,Mucosal inflammation,16921535
1,1,22.1,Diarrhoea,16921535
2,1,22.1,Fall,16921535
3,1,22.1,Rash,16921535
4,1,22.1,Dehydration,16921535
5,1,22.1,Fluid retention,16921535
0,5,22.1,General physical health deterioration,16921587
1,5,22.1,Deep vein thrombosis,16921587
2,5,22.1,Multiple organ dysfunction syndrome,16921587
0,5,22.1,Death,16921607
0,6,22.1,Adverse reaction,16921618
1,6,22.1,Pyrexia,16921618
2,6,22.1,Influenza,16921618
0,6,22.1,Ulcer,16921619
1,1,22.1,Tongue discomfort,16921619
2,1,22.1,Portal hypertension,16921619
3,1,22.1,Weight decreased,16921619
4,1,22.1,Fatigue,16921619
5,3,22.1,Diarrhoea,16921619
6,6,22.1,Wrong technique in product usage process,16921619
7,6,22.1,Faeces discoloured,16921619
8,6,22.1,Fall,16921619
9,6,22.1,Rib fracture,16921619
10,2,22.1,Diabetic foot,16921619
11,6,22.1,Alpha 1 foetoprotein increased,16921619
12,1,22.1,Hepatic encephalopathy,16921619
0,6,22.1,Dehydration,16921620
1,1,22.1,Diarrhoea,16921620
2,1,22.1,Vomiting,16921620
3,6,22.1,Alopecia,16921620
4,1,22.1,Renal failure,16921620
5,6,22.1,Taste disorder,16921620
6,1,22.1,Nausea,16921620
7,6,22.1,Malignant neoplasm progression,16921620
8,6,22.1,Back pain,16921620
9,6,22.1,Decreased appetite,16921620
0,5,22.1,Death,16921621
0,1,22.1,Campylobacter colitis,16921625
1,1,22.1,Hypoaesthesia,16921625
2,1,22.1,Cerebrovascular accident,16921625
3,1,22.1,Dysarthria,16921625
4,1,22.1,Ataxia,16921625
0,5,22.1,Death,16921633
0,1,22.1,Otitis media,16921636
0,1,22.1,Enteritis,16921643
1,5,22.1,Death,16921643
0,6,22.1,Pneumonitis,16921648
1,6,22.1,Adrenal insufficiency,16921648
2,6,22.1,Hypophysitis,16921648
3,6,22.1,Intentional product use issue,16921648
0,5,22.1,Death,16921651
0,3,22.1,Epistaxis,16921699
1,6,22.1,Pyrexia,16921699
2,3,22.1,Blood pressure increased,16921699
0,5,22.1,Death,16921710
0,3,22.1,Acute kidney injury,16921727
0,1,22.1,Deep vein thrombosis,16921876
1,1,22.1,Pulmonary embolism,16921876
0,2,22.1,Drug-induced liver injury,16921886
1,6,22.1,Transaminases increased,16921886
0,6,22.1,Shock haemorrhagic,16921901
0,6,22.1,Prostate cancer,16922026
1,6,22.1,Recurrent cancer,16922026
0,6,22.1,Toxicity to various agents,16922059
1,6,22.1,Product use in unapproved indication,16922059
2,6,22.1,Mucosal inflammation,16922059
0,6,22.1,Palmar erythema,16922061
1,6,22.1,Back pain,16922061
2,6,22.1,Pruritus,16922061
3,6,22.1,Throat irritation,16922061
4,6,22.1,Swollen tongue,16922061
5,6,22.1,Flushing,16922061
0,1,22.1,Invasive ductal breast carcinoma,16922181
1,1,22.1,Nausea,16922181
2,1,22.1,Neutropenia,16922181
3,1,22.1,Malignant neoplasm progression,16922181
0,6,22.1,Lymphoedema,16922240
1,6,22.1,Neutropenia,16922240
2,6,22.1,Concomitant disease aggravated,16922240
0,2,22.1,Dyspnoea,16922281
1,2,22.1,Chronic obstructive pulmonary disease,16922281
2,2,22.1,Exercise tolerance decreased,16922281
3,2,22.1,Fatigue,16922281
0,5,22.1,Intestinal ischaemia,16922296
1,6,22.1,Asthenia,16922296
2,6,22.1,Off label use,16922296
3,6,22.1,Neutropenia,16922296
4,6,22.1,Radiation skin injury,16922296
5,6,22.1,Lymphopenia,16922296
6,6,22.1,Gastrointestinal toxicity,16922296
7,6,22.1,Anal cancer recurrent,16922296
0,6,22.1,Asthma,16922299
0,6,22.1,Neoplasm progression,16922305
1,6,22.1,Hip arthroplasty,16922305
0,6,22.1,Desmoid tumour,16922310
0,3,22.1,Urinary incontinence,16922346
1,6,22.1,Micturition urgency,16922346
0,6,22.1,Malignant neoplasm progression,16922351
0,2,22.1,Chest pain,16922379
1,2,22.1,Ulcer,16922379
2,1,22.1,Stoma site haemorrhage,16922379
3,1,22.1,Haematemesis,16922379
0,5,22.1,Cholestasis,16922393
0,2,22.1,Toxic encephalopathy,16922407
